Bristol Myers Acquire Karuna Therapeutics in $14 Billion Megadeal
-
Drug News
Bristol Myers Acquire Karuna Therapeutics in $14 Billion Megadeal
In a strategic move, Bristol Myers Squibb has announced a groundbreaking acquisition of Karuna Therapeutics for a staggering $14 billion,…
Read More »
